IPROCHIM S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46 RON | -4.17% |
|
-4.17% | -22.69% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9.797 | 9.797 | 9.797 | 9.797 | 9.797 | 19.43 |
| Enterprise Value (EV) 1 | 10.63 | 10.31 | 9.96 | 9.86 | 10.37 | 20.24 |
| P/E ratio | - | -7.33 x | -23.1 x | 49.3 x | -5.62 x | 6.24 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.53 x | 1.46 x | 1.54 x | 1.4 x | 1.36 x | 2.59 x |
| EV / Revenue | 1.66 x | 1.54 x | 1.56 x | 1.41 x | 1.44 x | 2.7 x |
| EV / EBITDA | 29.8 x | -10.4 x | -94.8 x | 18.9 x | -7.65 x | 52 x |
| EV / FCF | -3,241 x | 11.3 x | -4 x | 97.6 x | 6.07 x | -10.5 x |
| FCF Yield | -0.03% | 8.88% | -25% | 1.02% | 16.5% | -9.52% |
| Price to Book | - | 0.1 x | 0.1 x | 0.1 x | 0.1 x | 0.13 x |
| Nbr of stocks (in thousands) | 327 | 327 | 327 | 327 | 327 | 327 |
| Reference price 2 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 59.50 |
| Announcement Date | 4/25/19 | 5/4/20 | 6/29/21 | 5/2/22 | 4/28/23 | 4/30/24 |
1RON in Million2RON
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 6.399 | 6.702 | 6.367 | 6.976 | 7.213 | 7.493 |
| EBITDA 1 | 0.3569 | -0.9908 | -0.105 | 0.5204 | -1.355 | 0.3891 |
| EBIT 1 | 0.0819 | -1.264 | -0.3889 | 0.228 | -1.674 | 0.1888 |
| Operating Margin | 1.28% | -18.87% | -6.11% | 3.27% | -23.2% | 2.52% |
| Earnings before Tax (EBT) 1 | 0.003215 | -1.337 | -0.4234 | 0.1989 | -1.744 | 3.112 |
| Net income 1 | 0.003215 | -1.337 | -0.4234 | 0.1989 | -1.744 | 3.112 |
| Net margin | 0.05% | -19.95% | -6.65% | 2.85% | -24.18% | 41.53% |
| EPS | - | -4.093 | -1.296 | 0.6091 | -5.340 | 9.529 |
| Free Cash Flow 1 | -0.003281 | 0.9159 | -2.492 | 0.101 | 1.707 | -1.927 |
| FCF margin | -0.05% | 13.67% | -39.14% | 1.45% | 23.67% | -25.72% |
| FCF Conversion (EBITDA) | - | - | - | 19.41% | - | - |
| FCF Conversion (Net income) | - | - | - | 50.78% | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/25/19 | 5/4/20 | 6/29/21 | 5/2/22 | 4/28/23 | 4/30/24 |
1RON in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.84 | 0.51 | 0.16 | 0.06 | 0.57 | 0.81 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.344 x | -0.5188 x | -1.556 x | 0.1224 x | -0.4213 x | 2.071 x |
| Free Cash Flow 1 | -0 | 0.92 | -2.49 | 0.1 | 1.71 | -1.93 |
| ROE (net income / shareholders' equity) | 0% | -1.35% | -0.43% | 0.2% | -1.81% | 2.59% |
| ROA (Net income/ Total Assets) | 0.05% | -0.76% | -0.24% | 0.14% | -1.06% | 0.1% |
| Assets 1 | 6.508 | 175.3 | 177.9 | 140.4 | 164.6 | 3,272 |
| Book Value Per Share | - | 301.0 | 300.0 | 300.0 | 290.0 | 446.0 |
| Cash Flow per Share | - | 1.640 | 2.710 | 3.020 | 1.470 | 0.2100 |
| Capex 1 | 0.08 | 0.16 | 0.18 | - | 0.04 | 2.88 |
| Capex / Sales | 1.19% | 2.43% | 2.87% | - | 0.54% | 38.41% |
| Announcement Date | 4/25/19 | 5/4/20 | 6/29/21 | 5/2/22 | 4/28/23 | 4/30/24 |
1RON in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- IPHI Stock
- Financials Iprochim S.A.
